(Q41634829)

English

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial

scientific article published on 31 December 2014

Statements

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial (English)
0 references
SAVOR-TIMI 53 Steering Committee and Investigators
Matthew A Cavender
Ofri Mosenzon
Ph Gabriel Steg
Jaime A Davidson
Jose C Nicolau
KyungAh Im
Amarachi A Umez-Eronini
Lawrence A Leiter
31 December 2014
696-705

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit